Overview
- The Teal Wand, developed by Teal Health, allows women aged 25–65 to self-collect vaginal samples at home for HPV testing, matching the accuracy of clinician-collected samples.
- The FDA approval is based on clinical trials involving over 600 women, demonstrating 96% accuracy in detecting HPV, the leading cause of cervical cancer.
- The test requires a prescription obtained through Teal Health's telehealth platform, with follow-up care provided if results are positive.
- Teal Health plans to launch the test in California in June, with efforts underway to expand nationwide and secure insurance coverage.
- Experts emphasize that the test supplements, but does not replace, regular gynecological exams, which screen for additional health concerns.